Organization · Venture Capital
LongeVC
LongeVC is a venture capital firm based in Washington D.C. that invests in early-stage biotechnology and longevity-focused companies. They aim to support founders in bringing innovative biotech solutions to market.
Overview
What LongeVC does
What LongeVC is
LongeVC is a venture capital firm based in Washington D.C. that invests in early-stage biotechnology and longevity-focused companies. They aim to support founders in bringing innovative biotech solutions to market.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find LongeVC elsewhere
Open the official website or a supported primary organization account.
Capability profile
LongeVC as a funder
Investment thesis
LongeVC focuses on investing in biotechnology and longevity, supporting early-stage founders to bring breakthrough biotech solutions to market.
Focus narrative
LongeVC invests in early-stage companies that are developing innovative solutions in personalized medicine, advanced diagnostics, and foundational platform technologies. Their investment thesis includes pre-clinical and clinical stage drug development companies that explore the molecular and cellular mechanisms of aging, as well as integrated healthcare solutions that facilitate faster drug discovery and testing.
Value beyond capital
LongeVC provides strategic support to its portfolio companies, leveraging its expertise in biotechnology and longevity to help founders navigate the complexities of drug development and market entry. The firm aims to facilitate connections within the industry and provide resources that enhance the growth and success of its investments.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 25
Portfolio context
LongeVC's portfolio includes notable companies such as Trogenix, which develops precision cancer treatments; Stealth Company, focusing on in vivo biofactories; and CatenaBio, creating novel therapeutics. Other companies include Turn.bio, which develops mRNA medicines, and Insilico Medicine, utilizing AI for drug discovery. The portfolio also features Medici Therapeutics, Basepaws, and Deep Longevity, among others, showcasing a diverse range of innovative biotech solutions.
Common questions
What to know about LongeVC
Upseed classifies LongeVC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.